Sector Update: Health Care Stocks Retreat Late Afternoon

MT Newswires Live10-03

Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index shedding 0.4% and the Health Care Select Sector SPDR Fund (XLV) down 0.3%.

The iShares Biotechnology ETF (IBB) rose 0.4%.

In corporate news, Taysha Gene Therapies (TSHA) shares surged 53% after the company said its TSHA-102 in Rett syndrome was granted breakthrough therapy designation by the US Food and Drug Administration.

Bolt Biotherapeutics (BOLT) shares dropped nearly 10%, a day after the company said it plans to shed 50% of its staff to save cash.

Humana (HUM) shares rose 4.2% after the company reported preliminary 2026 Medicare Advantage Star Ratings and reaffirmed its earnings outlook for fiscal 2025.

Anavex Life Sciences (AVXL) said its phase 1b trial comparing a modified-release tablet of its Anavex 3-71 formulation with its current immediate-release oral capsule met its primary endpoints of safety and tolerability in male and female participants 18 years old and older with schizophrenia. The stock rose 1.6%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2572540756?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-03 03:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572540756","market":"hk","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Retreat Late Afternoon","media":"MT Newswires Live","content":"<html><body><p> Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index shedding 0.4% and the Health Care Select Sector SPDR Fund (XLV) down 0.3%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) rose 0.4%.</p><p>In corporate news, <a href=\"https://laohu8.com/S/TSHA\">Taysha Gene Therapies</a> (TSHA) shares surged 53% after the company said its TSHA-102 in Rett syndrome was granted breakthrough therapy designation by the US Food and Drug Administration.</p><p><a href=\"https://laohu8.com/S/BOLT\">Bolt Biotherapeutics</a> (BOLT) shares dropped nearly 10%, a day after the company said it plans to shed 50% of its staff to save cash.</p><p>Humana (HUM) shares rose 4.2% after the company reported preliminary 2026 Medicare Advantage <a href=\"https://laohu8.com/S/SGU\">Star</a> Ratings and reaffirmed its earnings outlook for fiscal 2025.</p><p><a href=\"https://laohu8.com/S/AVXL\">Anavex Life</a> Sciences (AVXL) said its phase 1b trial comparing a modified-release tablet of its Anavex 3-71 formulation with its current immediate-release oral capsule met its primary endpoints of safety and tolerability in male and female participants 18 years old and older with schizophrenia. The stock rose 1.6%.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Retreat Late Afternoon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Retreat Late Afternoon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-03 03:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index shedding 0.4% and the Health Care Select Sector SPDR Fund (XLV) down 0.3%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) rose 0.4%.</p><p>In corporate news, <a href=\"https://laohu8.com/S/TSHA\">Taysha Gene Therapies</a> (TSHA) shares surged 53% after the company said its TSHA-102 in Rett syndrome was granted breakthrough therapy designation by the US Food and Drug Administration.</p><p><a href=\"https://laohu8.com/S/BOLT\">Bolt Biotherapeutics</a> (BOLT) shares dropped nearly 10%, a day after the company said it plans to shed 50% of its staff to save cash.</p><p>Humana (HUM) shares rose 4.2% after the company reported preliminary 2026 Medicare Advantage <a href=\"https://laohu8.com/S/SGU\">Star</a> Ratings and reaffirmed its earnings outlook for fiscal 2025.</p><p><a href=\"https://laohu8.com/S/AVXL\">Anavex Life</a> Sciences (AVXL) said its phase 1b trial comparing a modified-release tablet of its Anavex 3-71 formulation with its current immediate-release oral capsule met its primary endpoints of safety and tolerability in male and female participants 18 years old and older with schizophrenia. The stock rose 1.6%.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HUM","symbol_name":"哈门那","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2572540756","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572540756","pubTimestamp":1759435123,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index shedding 0.4% and the Health Care Select Sector SPDR Fund (XLV) down 0.3%.The iShares Biotechnology ETF (IBB) rose ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HUM":"哈门那","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","LU0238689110.USD":"贝莱德环球动力股票基金","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4581":"高盛持仓","AVXL":"Anavex Life Sciences Corp.","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LABU":"三倍做多标普生物-Direxion","BK4139":"生物科技","BK7500":"支付概念","BK4533":"AQR资本管理(全球第二大对冲基金)","TSHA":"Taysha Gene Therapies, Inc.","XLV":"健康照护类股ETF-SPDR","HUM.AU":"HUMM GROUP LTD","XBI":"SPDR S&P Biotech ETF","BK4566":"资本集团","BK7093":"消费信贷","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","BK4588":"碎股","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BOLT":"Bolt Biotherapeutics, Inc.","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","BK4154":"管理型保健护理","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","IBB":"生物科技指数ETF-iShares Nasdaq","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD"},"translate_title":"行业更新：医疗保健股午后回落","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TSHA":1,"XBI":0.6,"IBB":1,"BOLT":1,"XLV":1,"LABU":0.6,"HUM.AU":1,"AVXL":1,"HUM":1},"content_text":"Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index shedding 0.4% and the Health Care Select Sector SPDR Fund (XLV) down 0.3%.The iShares Biotechnology ETF (IBB) rose 0.4%.In corporate news, Taysha Gene Therapies (TSHA) shares surged 53% after the company said its TSHA-102 in Rett syndrome was granted breakthrough therapy designation by the US Food and Drug Administration.Bolt Biotherapeutics (BOLT) shares dropped nearly 10%, a day after the company said it plans to shed 50% of its staff to save cash.Humana (HUM) shares rose 4.2% after the company reported preliminary 2026 Medicare Advantage Star Ratings and reaffirmed its earnings outlook for fiscal 2025.Anavex Life Sciences (AVXL) said its phase 1b trial comparing a modified-release tablet of its Anavex 3-71 formulation with its current immediate-release oral capsule met its primary endpoints of safety and tolerability in male and female participants 18 years old and older with schizophrenia. The stock rose 1.6%.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2572540756","isCrawlerRequest":true}